期刊论文详细信息
Revista Cubana de Hematología, Inmunología y Hemoterapia
Chronic granulomatous disease
Arce Hernández, Ada A1  García García, Idrián2  Macías Abraham, Consuelo1  Sánchez Segura, Miriam1  Villaescusa Blanco, Rinaldo1  Marsán Suárez, Vianed1  Palma Salgado, Lourdes1  del Valle Pérez, Lázaro O1 
[1] Instituto de Hematología e Inmunología, La Habana, Cuba;Centro de Ingeniería Genética y Biotecnología, La Habana, Cuba
关键词: inmunodeficiencia primaria;    enfermedad granulomatosa crónica;    infecciones recurrentes;   
DOI  :  
学科分类:生理学与病理学
来源: SciELO
PDF
【 摘 要 】

Chronic granulomatous disease (CGD) is a primary immunodeficiency with a defect of the phagocytosis process. A 13 year-old adolescent with recurrent life-threatening episodes since one month of birth is presented. The main clinical manifestations included diarrhea, stomatitis, cellulitis, lymphadenitis, pneumonia, granuloma formation, pulmonary tuberculosis, pulmonary and hepatic abscesses. Physical examination showed poor growth, hepatomegaly, adenopathies, hyperextension of extremities and chronic gingivitis. Immunological studies showed normal concentrations of immunoglobulins (Ig): IgM: 0,98 g/L (0,69 - 2,69 g/L), IgA: 2,76 g/L (1,58 - 3,94 g/L) and IgE: 11,70 UI/mL ( < 50 UI/ml), C3 and C4 (1,28 g/L (0,9 - 1,7 g/L) and 0,30 g/L (0,2 - 0,4 g/L), respectively, and hypergammaglobulinemia of 17,2 g/L (7,81 - 15,30 g/L). Lymphocytes count T CD3, CD4 and CD8 positive were normal: 62 % (52 - 78 %), 45 % (25 - 48 %) y 15 % (9 - 35 %) and B lymphocytes count was also normal: 24 % (8 - 24 %). Opsonophagocytic index was normal at time 15 and 60 minutes: 35 % (22,99 - 53,95 %) and 12,50 % (6,63 - 28,43 %), respectively. Diagnosis was confirmed with negative nitroblue tetrazolium test . Treatment with antibiotics, fungistats, as well as gamma interferon contributed to a favorable response, presenting a lower amount of infectious episodes as well as a recovery of weight and height. Early diagnosis and treatment of CGD has improved prognosis and reduced patients´ morbidity and mortality.

【 授权许可】

Unknown   

【 预 览 】
附件列表
Files Size Format View
RO201911300326682ZK.pdf 152KB PDF download
  文献评价指标  
  下载次数:5次 浏览次数:3次